Table 2.
Characteristics | Toxoplasma positive no. (%) | Toxoplasma negative no. (%) | Total no. (%) | P-value |
---|---|---|---|---|
Gender | 0.5 | |||
Male | 13 (21.3) | 48 (78.7) | 61 (67.8) | |
Female | 6 (20.7) | 23 (79.3) | 29 (32.2) | |
| ||||
Age groups (year) | 0.05 | |||
20–29 | 5 (26.3) | 19 (79.2) | 24 (23.3) | |
30–39 | 10 (19.2) | 42 (71.8) | 52 (57.8) | |
40–49 | 1 (10.0) | 9 (90.0) | 10 (11.1) | |
≥50 | 3 (75.0) | 1 (25.0) | 4 (4.4) | |
| ||||
Living area (residence) | 0.64 | |||
Urban | 17 (28.4) | 63 (71.6) | 80 (88.9) | |
Rural | 2 (20.0) | 8 (80.0) | 10 (11.1) | |
| ||||
Education level | 0.57 | |||
Illiterate | 4 (22.2) | 14 (77.8) | 18 (20.0) | |
Educated (at least primary school) | 15 (20.8) | 57 (79.2) | 72 (80.0) | |
| ||||
Disease duration (month) | 0.59 | |||
≥12 | 6 (20.7) | 23 (79.3) | 29 (32.2) | |
≤12 | 13 (21.3) | 48 (78.7) | 61 (67.8) | |
| ||||
Marital status | 0.22 | |||
Married | 18 (23.1) | 60 (76.9) | 78 (86.7) | |
Single | 1 (8.3) | 11 (91.7) | 12 (13.3) | |
| ||||
Antiretroviral therapy | 0.02 | |||
Yes | 3 (5.1) | 56 (94.9) | 59 (65.6) | |
No | 16 (51.6) | 15 (48.4) | 31 (34.4) | |
| ||||
Neurological symptoms | 0.42 | |||
Yes | 8 (23.5) | 26 (76.5) | 34 (37.8) | |
No | 11 (19.6) | 45 (80.4) | 56 (62.2) | |
| ||||
CD4+ cell count (cells/μl) | 0.042 | |||
<100 | 14 (33.3) | 28 (66.7) | 42 (46.6) | |
100–500 | 3 (8.6) | 32 (91.4) | 35 (38.8) | |
>500 | 2 (5.4) | 11 (84.6) | 13 (14.6) |